Complete solutions to increase success rates for your drug development programs
Operating out of Europe we are specialized in key disciplines to enable Precision Medicine – from Biomarker discovery to applications in clinical routine
Our service offer is based on 3 pillars covering key needs of Precision Medicine approaches
Precision Medicine service offer
Our service offer covers the needs of pharmaceutical industry across the drug discovery development commercialisation continuum
- Biomarker discovery and comprehensive programs in translational research
- Broad biomarker menu & customized assay development
- Clinical trial assay & companion diagnostics development services
- Suport of clinical trial enrolment through Medicover´s broad network
- Global central lab clinical testing
- Product commercialisation through our large lab network and CAP-CLIA lab
- Complemented by Central Lab Services and Biospecimen Management
We are a one stop shop delivering outstanding services to our clients by applying:
- Scientific, technical and operational excellence
- World class quality standards, certifications and accreditations
- Comprehensive quality management systems including method validation, SOPs, quality controls and quality assurance
- Extensive GxP-ready analytical plans and reports
- Data privacy / data protection requirements
Under consideration of the specific regulatory requirements our service offer is split
BIOMARKER SERVICES Biomarker discovery and comprehensive programs in translational research based on a broad biomarker menu & customized assay development, e.g. for exploratory biomarkers
CTA/CDx development Fit for purpose assay development from patient selection in clinical trials to market ready assay
IVD commercialization Rapid test adoption and commercialization of your IVD / companion diagnostics through our large network of routine testing and CLIA-CAP laboratories
Application examples
Our service offer comprises a huge range of applications
- Tumor molecular profiling
- Liquid biopsy ctDNA testing
- Gene-target quantification for T-cell therapy
- SNP genotyping for patient inclusion / exclusion
- Hereditary cancer testing
- Exosomal miRNA profiling for early sepsis diagnosis
- Prognostic microbiome profiling of stool samples
- Microbiome profiling of stool samples to evaluate treatment effect
- Microbiome profiling of treated skin samples
- Pathogen screening